임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
26건 표시
- 2상모집 중· Small Cell Lung Cancer ( SCLC )Study of Sacituzumab Govitecan With Atezolizumab/Durvalumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer
협력: 길리어드
- 2상모집 중· Advanced Microsatellite Stable Colorectal CancerStudy of Denikitug (GS-1811) Given Alone or With Nivolumab or With Chemotherapy in Adults With Advanced Colorectal Cancer
리드: 길리어드
- 2상모집 중· Hematopoietic and Lymphatic System NeoplasmRemdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals
협력: 길리어드
- 2상모집 중· Squamous Cell Carcinoma of Head and NeckA Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)
협력: 길리어드
- 2상모집 중· Salivary Gland CancerSacituzumab Govitecan in Metastatic Salivary Gland and Thyroid Cancers (SG-SGTC)
협력: 길리어드
- 2상모집 중· Locally Advanced Gastric AdenocarcinomaZimberelimab Anti-PD1 +/- Domvanalimab in Resectable Mmrd Gastric Cancer
협력: 길리어드
- 2상모집 중· Urothelial CarcinomaAdjuvant Sacituzumab Govitecan and Nivolumab in Muscle-Invasive Urothelial Carcinoma at High-Risk Recurrence
협력: 길리어드
- 2상모집 중· Esophageal Squamous Cell CarcinomaSacituzumab Govitecan for Advanced Esophageal Squamous Cell Carcinoma
협력: 길리어드
- 2상모집 중· Ulcerative ColitisStudy of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative Colitis
리드: 길리어드
- 2상모집 중· Cervical CancerA Study of Sacituzumab Govitecan (IMMU-132) in Patients With Recurrent or Persistent Cervical Cancer
협력: 길리어드
- 2상모집 중· Metastatic Urothelial CancerStudy of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread
리드: 길리어드
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.